Porphyrin photosensitised processes in the prevention and treatment of water- and vector-borne diseases

Current Medicinal Chemistry

Volumn 19, Issue 6, 2012, Pages 808-819

  Coppellotti, O ^a   Fabris, C ^a   Soncin, M ^a   Magaraggia, M ^a   Camerin, M ^a   Jori, G ^a   Guidolin, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bacteria; Fungi; Mosquito larvae; Parasitic protozoa metazoa; Photosensitization; Porphyrins; Vector borne diseases; Water borne diseases

Indexed keywords

AMINOLEVULINIC ACID; BEVACIZUMAB; CHLORIN; CHLORIN E6; CHLOROPHYLL; HEMATOPORPHYRIN; HYPOCRELLIN B; MEROCYANINE; PHEOPHORBIDE; PHTHALOCYANINE; PORPHYRIN; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; UNCLASSIFIED DRUG; VERTEPORFIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM; CHAGAS DISEASE; CHORIORETINITIS; DISEASE CARRIER; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; FUNGUS; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; KERATITIS; NONHUMAN; PARASITE; PHOTOSENSITIZATION; PROTOZOON; SKIN LEISHMANIASIS; WATER CONTAMINATION;

ANIMALS; ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; DISEASE VECTORS; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; WATER POLLUTANTS;

EID: 84857603383     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712799034905     Document Type: Article

References (110)

1. Baptista, M.S.; Wainwright, M. Photodynamic antimicrobial chemotherapy (PACT) for the treatment of malaria, leishmaniasis and trypanosomiasis. Braz. J. Med. Biol. Res., 2011, 44, 1-10.
2. Packer, L.; Sies, H. Singlet oxygen, UVA and ozone. In: Methods in Enzymology, Academic: San Diego, 2000, 319.
3. Wainwright, M. Photodynamic antimicrobial chemotherapy (PACT). J. Antimicrob. Chemother., 1998, 42, 13-28.
4. Wainwright, W. Photoantimicrobials-A PACT against resistance and infection. Drugs Fut., 2004, 29, 85-93.
5. Jori, G.; Coppellotti, O. Inactivation of pathogenic microorganisms by photodynamic techniques: Mechanistic aspects and perspective applications. Anti-Infect. Agents Med. Chem., 2007, 6, 119-131. (Pubitemid 46681782)
6. Jori, G.; Fabris, C.; Soncin, M.; Ferro, S.; Coppellotti, O.; Dei, D.; Fantetti, L., Chiti, G.; Roncucci, G.; Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications. Lasers Surg. Med., 2006, 38, 468-481.
7. Hamblin, M.R.; Hasan, T. Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci., 2004, 3, 436-450. (Pubitemid 38855151)
8. Ben Amor, T.; Bortolotto, L.; Jori , G. Porphyrins and related compounds as photoactivatable insecticides. 3. Laboratory and field studies. Photochem. Photobiol., 2000, 71, 124-128.
9. Erzinger, G.S., Wohllebe, S., Vollrath, F., Souza, S.C., Richter, P., Lebert, M., Häder, D.P. Optimizing conditions for the use of chlorophyll derivatives for photodynamic control of parasites in aquatic ecosystems. Parasitol. Res. 2011, 109, 781-786.
10. Reddi, E.; Ceccon, M.; Valduga, G.; Jori, G.; Bommer, J.C.; Elisei, F.; Latterini, L.; Mazzucato, U. Photophysical properties and antibacterial activity of meso-substituted cationic porphyrins. Photochem. Photobiol., 2002, 75, 462-470.
11. Ochsner, M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J. Photochem. Photobiol. B, 1997, 39, 1-18. (Pubitemid 27285576)
12. Jori, G. Photodynamic therapy of microbial infections: State of the art and perspectives. J. Environ. Pathol. Toxicol. Oncol., 2006, 25, 505-519. (Pubitemid 43341261)
13. De Rosa, M.; Crutchley, R. Photosensitized singlet oxygen and its applications. Coord. Chem. Rev., 2002, 233, 351-371.
14. Spikes, J.D.; Livingston, R. In: Advances in Radiation Biology; Augenstein, L.G.; Mason, R.; Zelle, M. Eds; Academic Press, New York, 1969, vol.3, pp 30-121.
15. Dougherty, T.J.; Gomer, C.J.; Henderson, B.W.; Jori, G.; Kessel, D.; Korbelik. M.; Moan, J.; Peng, Q. Photodynamic therapy. J. Natl. Cancer. Inst., 1998, 90, 889-905. (Pubitemid 28304157)
16. Dolmans, D.E.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer., 2003, 3, 380-387. (Pubitemid 37328858)
17. Wormald, R.; Evans, J.; Smeeth, L.; Henshaw, K. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst. Rev., 2005, 4, CD002030.
18. Pottier, R.; Krammer, B.; Stepp, H.; Baumgartner, R. Photodynamic Therapy with ALA: A Clinical Handbook, Royal Society of Chemistry: Cambridge, UK, 2005.
19. Hamblin, M.R.; Jori, G. Photodynamic Inactivation of Microbial Pathogens: Medical and Environmental Applications, Royal Society of Chemistry: Cambridge, UK 2011.
20. Owens, R.C.Jr. Antimicrobial stewardship: Concepts and strategies in the 21st century. Diagn Microbiol Infect Dis., 2008, 61, 110-128. (Pubitemid 351509755)
21. Merchat, M.; Bertolini, G.; Giacomini, P.; Villanueva, A.; Jori, G. Mesosubstituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria. J. Photochem. Photobiol. B., 1996, 32, 153-157. (Pubitemid 26127371)
22. Minnock, A.; Vernon, D.I.; Schofield, J.; Griffiths, J.; Parish, J.H.; Brown, S.T. Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria. J. Photochem. Photobiol. B., 1996, 32, 159-64. (Pubitemid 26127372)
23. Soncin, M.; Fabris, C.; Busetti, A.; Dei, D.; Nistri, D.; Roncucci, G.; Jori, G. Approaches to selectivity in the Zn(II)-phthalocyanine-photosensitized inactivation of wild-type and antibiotic-resistant Staphylococcus aureus. Photochem. Photobiol. Sci., 2002, 1, 815-819. (Pubitemid 37069803)
24. Bombelli, C.; Bordi, F.; Ferro, S.; Giansanti, L.; Jori, G.; Mancini, G.; Mazzuca, C.; Monti, D.; Ricchelli, F.; Sennato, S.; Venanzi, M. New cationic liposomes as vehicles of m-tetrahydroxyphenylchlorin in photodynamic therapy of infectious diseases. Mol. Pharm., 2008, 5, 672-679.
25. Huang, L.; Huang, Y.Y; Mroz, P.; Tegos, G.P.; Zhiyentayev, T.; Sharma, S.K.; Lu, Z.; Balasubramanian, T.; Krayer, M.; Ruzié, C.; Yang, E.; Kee, H.L.; Kirmaier, C.; Diers, J.R.; Bocian, D.F.; Holten, D.; Lindsey, J.S.; Hamblin, M.R. Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob Agents Chemother., 2010, 54, 3834-3841.
26. Demidova, T.N.; Hamblin, M.R. Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl. Environ. Microbiol., 2005, 71, 6918-6925. (Pubitemid 43194181)
27. Kassab, K.; Ben Amor, T.; Jori, G.; Coppellotti, O. Photosensitization of Colpoda inflata cysts by meso-substituted cationic porphyrins. Photochem. Photobiol. Sci., 2002, 1, 560-564. (Pubitemid 37069763)
28. Maisch, T.; Szeimies, R.M.; Jori, G.; Abels, C. Antibacterial photodynamic therapy in dermatology. Photochem. Photobiol. Sci., 2004, 3, 907-917. (Pubitemid 39504589)
29. Jori, G.; Camerin, M.; Soncin, M.; Giudolin, L.; Coppellotti, O. In: Photodynamic Inactivation of Microbial Pathogens: Medical and Environmental Applications; Hamblin, M.R.; Jori, G. Eds, Royal Society of Chemistry: Cambridge, UK, 2011, pp1-18.
30. Caminos, D.A.; Durantini, E.N. Synthesis of asymmetrically mesosubstituted porphyrins bearing amino groups as potential cationic photodynamic agent. J. Porph. Phthaloc., 2005, 9, 334-342. (Pubitemid 41133928)
31. Bonnett, R.; Krysteva, M.A.; Lalov, I.G.; Artarsky, S.V. Water disinfection using photosensitizers immobilized on chitosan. Water Res., 2006, 40, 1269-1275. (Pubitemid 43374905)
32. Polo, L.; Segalla, A.; Bertoloni, G.; Jori, G.; Schaffner, K.; Reddi, E. Polylysine-porphycene conjugates as efficient photosensitizers for the inactivation of microbial pathogens. J. Photochem. Photobiol. B., 2000, 59, 152-158. (Pubitemid 32273351)
33. Hamblin, M.R.; O'Donnell, D.A.; Murthy, N.; Rajagopalan, K.; Michaud, N.; Sherwood, M.E.; Hasan, T. Polycationic photosensitizer conjugates: Effects of chain length and Gram classification on the photodynamic inactivation of bacteria. J. Antimicrob. Chemother., 2002, 49, 941-951. (Pubitemid 34692888)
34. Tegos, G.P.; Anbe, M.; Yang, C.; Demidova, T.N.; Satti, M.; Mroz, P.; Janjua, S.; Gad, F.; Hamblin, M.R. Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob. Agents Chemother., 2006, 50, 1402-1410.
35. Tsai, T.; Yang, Y.T.; Wang, T.H.; Chien, H.F.; Chen, C.T. Improved photodynamic inactivation of gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles. Lasers Surg. Med., 2009, 41, 316-322.
36. Merchat, M.; Spikes, J.D.; Bertoloni, G.; Jori, G. Studies on the mechanism of bacteria photosensitization by meso-substituted cationic porphyrins. J. Photochem. Photobiol. B., 1996, 35, 149-157. (Pubitemid 26383615)
37. Ferro, S.; Ricchelli, F.; Monti, D.; Mancini, G.; Jori, G. Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome. Int. J. Biochem. Cell. Biol., 2007, 39, 1026-1034. (Pubitemid 46575332)
38. Ferro, S.; Jori, G.; Sortino, S.; Stancanelli, R.; Nikolov, P.; Tognon, G.; Ricchelli, F.; Mazzaglia, A. Inclusion of 5-[4-(1-dodecanoylpyridinium)]-10, 15,20-triphenylporphine in supramolecular aggregates of cationic amphiphilic cyclodextrins: Physicochemical characterization of the complexes and strengthening of the antimicrobial photosensitizing activity. Biomacromoleculs, 2009, 10, 2592-2600.
39. Cheng, Y.; Samia, A.; Meyers, J.D.; Panagopoulos, I.; Fei, B.; Burda, C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J. Am. Chem. Soc., 2008, 130, 10643-10647.
40. Perni, S.; Prokopovich, P.; Pratten, J.; Parkin, I.P.; Wilson, M. Nanoparticles: Their potential use in antibacterial photodynamic therapy. Photochem. Photobiol. Sci., 2011, 10, 712-720.
41. Schwiertz, J.; Wiehe, A.; Gräfe, S.; Gitter, B.; Epple, M. Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria. Biomaterials. 2009, 30, 3324-3331.
42. Xing, C.; Xu, Q.; Tang, H.; Liu, L.; Wang, S. Conjugated polymer/porphyrin complexes for efficient energy transfer and improving light-Activated antibacterial activity. J. Am. Chem. Soc., 2009, 131, 13117-13124.
43. Carvalho, C.M.; Alves, E.; Costa, L.; Tomé, J.P.; Faustino, M.A.; Neves, M.G.; Tomé, A.C.; Cavaleiro, J.A.; Almeida, A.; Cunha, A.; Lin, Z.; Rocha, J. Functional cationic nanomagnet-porphyrin hybrids for the photoinactivation of microorganisms. ACS Nano., 2010, 4, 7133-7140.
44. Banerjee, I.; Mondal, D.; Martin, J.; Kane, R.S. Photoactivated antimicrobial activity of carbon nanotube-porphyrin conjugates. Langmuir., 2010, 26, 17369-17374.
45. Rosenthal, J.P.; Jessup, C.M. Global climate change and health: Developing a research agenda for the NIH. Trans. Am. Clin. Climatol. Ass., 2009, 120, 129-141.
46. Patz , J.A.; Vavrus, S.J.; Uejio, C.K.; McLellan, S.L. Climate change and waterborne disease risk in the Great Lakes Region Of the U.S. Am. J. Prev. Med. 2008, 35, 451-458.
47. Rodo, X.; Pascual, M; Fuchs, G.; Faruque, A.S. ENSO and cholera: A nonstationay link related to climate change? Proc. Natl. Acad. Sci. U S A. 2002, 99, 12901-12906.
48. Anyamba, A; Chretien, J. P.; Small, J.; Tucker, C.J.; Linthicum, K.J. Developing global climate anomalies suggest potential disease risks for 2006-2007. Int. J. Health Geogr. 2006, 5, 60-68.
49. Schuster, C. J.; Ellis, A.; Robertson, W. J.; Charron, D. F.; Aramini J. J.; Marshall, B.; Medeiros, D. T. Infectious disease outbreaks related to drinking water in Canada, 1974-2001. Can. J. Public Health. 2005, 96, 254-258.
50. WHO, Burden of disease and cost-effectiveness estimates, 2011.
51. WHO, Water recreation and disease. Plausibility of associated infections: Acute effects, sequelae and mortality, 2005.
52. Huq, A,; Whitehouse, C.A,; Grim, C.J.; Alam, M.; Colwell. R.R.; Biofilms in water, its role and impact in human disease transmission. Curr. Opin. Biotechnol. 2008, 19, 244-247.
53. Wong, T.W.; Wang, Y.Y.; Sheu, H.S.; Chuang, Y.C. Bactericidal Effects of Toluidine Blue-Mediated Photodynamic Action on Vibrio vulnificus. Antimicrob. Agents Chemoter. 2005, 49(3), 895-902.
54. Alves, E; Faustino, M.A.F.; Tomé, J.P.C.; Neves, M.G.P.M.; Tomé, A.C.; Cavaleiro, J.A.S.; Cunha, A.; Newton C. M. Gomes, Almeida, A. Photodynamic Antimicrobial Chemotherapy in Aquaculture: Photoinactivation Studies of Vibrio fischeri. PLoS One. 2011, 6 (6), e20970.
55. WHO Guidelines for the safe use wastewater excreta and greywater. Vol II. Wastewater use in Agriculture 2006.
56. Jemli, M.; Alouini, Z.; Sabbahi, S.; Gueddari, M. Destruction of fecal bacteria in wastewater by three photosensitizers. J. Environ. Monit., 2002, 4, 511-516. (Pubitemid 34864579)
57. Park, J.H.; Moon, Y.H.; Bang, I.S.; Kim, Y.C.; Kim, S.A.; Ahn, S.G.; Yoon, J.H. Antimicrobial effect of photodynamic therapy using a highly pure chlorin e6. Lasers Me. Sci., 2010, 25, 705-710.
58. Garcez, A.S.; Ribeiro, M.S.; Tegos, G.P.; Núez, S.C.; Antonio O.C. Jorge, A.O.C.; Hamblin, M.R. Antimicrobial Photodynamic Therapy Combined With Conventional Endodontic Treatment to Eliminate Root Canal Biofilm Infection. Lasers Surg. Med., 2007, 39, 59-66.
59. Close, M.; Dann, R.; Ball, A.; Pirie, R.; Savill, M.; Smith, Z. Microbial groundwater quality and its health implications for a border-strip irrigated dairy farm catchment, South Island, New Zealand. J. Water Health. 2008, 6(1), 83-98. (Pubitemid 351320991)
60. Rovaldi, C.R.; Pievsky, A.; Sole, N.A.; Friden, P.M.; Rothstein D.M.; Spacciapoli, P. Photoactive porphyrin derivative with broad-spectrum activity against oral pathogens in vitro. Antimicrob. Agents Chemother. 2000, 44(12), 3364-3367. (Pubitemid 33009496)
61. Ghosh, J.; Larsson, P.; Singh, B.; Pettersson, B.M.; Islam, N.M.; Sarkar, S.N.; Dasgupta, S.; Kirsebom, L.A. Sporulation in mycobacteria. Proc. Natl. Acad. Sci. U S A. 2009 106(26),10781-10786.
62. O'Riordan, K,; Sharlin, D.S.; Gross, J.; Chang, S.; Errabelli, D.; Akilov, O.E.; Kosaka, S.; Nau, G.J.; Hasan, T. Photoinactivation of mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCGinduced granulomatous infection. Antimicrob. Agents Chemother. 2006, 50(5), 1828-1834.
63. Schuster, F. L.; Visvesvara, G.S. Opportunistic amoebae: Challenges in prophylaxis and treatment. Drug Resist. Updat., 2004, 7, 41-45.
64. Chávez-Munguía, B.; Omaña-Molina, M.; González-Lázaro, M.;González-Robles, A.; Bonilla, P.; Martínez-Palomo, A. Ultrastructural study of encystation and excystation in Acanthamoeba castellanii. J. Eukaryot. Microbiol., 2005, 52, 153-158. (Pubitemid 43934164)
65. Lloyd, D.; Turner, N.A.; Khunkitti, W.; Hann, A.C.; Furr, J.R.; Russell, A.D. Encystation in Acanthamoeba castellanii: Development of biocide resistance. J. Eukaryot. Microbiol., 2001, 48, 11-16. (Pubitemid 32180364)
66. Marciano-Cabral, F.; Cabral, G. Acanthamoeba spp. as agents of disease in humans. Clin. Microbiol. Rev., 2003, 16, 273-307. (Pubitemid 36519813)
67. Chen, Z.; Xuguang, S.; Zhiqun, W.; Ran, L. In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba. Br. J. Ophthalmol., 2008, 92, 1283-1286.
68. Kassab, K.; Dei, D.; Roncucci, G.; Jori, G.; Coppellotti, O. Phthalocyaninephotosensitized inactivation of a pathogenic protozoan, Acanthamoeba palestinensis. Photochem. Photobiol. Sci., 2003, 2, 668-672. (Pubitemid 41646663)
69. Ferro, S.; Coppellotti, O.; Roncucci, G.; Ben Amor, T.; Jori, G. Photosensitized inactivation of Acanthamoeba palestinensis in the cystic stage. J. Appl. Microbiol., 2006, 101, 206-212. (Pubitemid 43952020)
70. Ferro, S.; Guidolin, L.; Tognon, G.; Jori, G.; Coppellotti, O. Mechanisms involved in the photosensitized inactivation of Acanthamoeba palestinensis trophozoites. J. Appl. Microbiol., 2009, 107, 1615-1623.
71. Mauget-Faysse, M.; Mimoun, G.; Ruiz-Moreno, J. M.; Quaranta-El Maftouhi, M.; De Laey, J. J.; Postemans, L.; Soubrane, G.; Defauchy, M.; Leys, A. Verteporfin photodynamic therapy for choro, idal neovascularization associated with toxoplasmic retinochoroiditis. Retina, 2006, 26, 396-403. (Pubitemid 44197630)
72. Neri, P.; Mercanti, L.; Mariotti, C.; Salvolini, S.; Giovannini, A. Long-term control of choroidal neovascularization in quiescent congenital toxoplasma retinochoroiditis with photodynamic therapy: 4-year results. Int. Ophthalmol., 2010, 30, 51-56.
73. Rishi, P.; Venkataraman, A.; Rishi, E. Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis. Indian J. Ophthalmol., 2011, 59, 62-64.
74. Osorio, S.; de la Cámara, R.; Monteserin, M.C.; Granados, R.; Oña, F.; Rodriguez-Tudela, J.L.; Cuenca-Estrella, M. Recurrent disseminated skin lesions due to Metarhizium anisopliae in an adult patient with acute myelogenous leukemia. J. Clin. Microbiol., 2007, 45, 651-655.
75. Calzavara-Pinton, P.G.; Venturini, M.; Sala, R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J. Photochem. Photobiol. B: Biol., 2005, 78, 1-6. (Pubitemid 40090155)
76. Zoladek, T.; Nguyen, B.N.; Jagiello, I.; Graczyk, A.; Rytka, J. Diamino acid derivatives of porphyrins penetrate into yeast cells, induce photodamage, but have no mutagenic effect. Photochem. Photobiol.,1997, 66, 253-259. (Pubitemid 127470174)
77. Calzavara-Pinton, P.G.; Rossi, M.T.; Ortel, B. In: Photodynamic inactivation of microbial pathogens. Medical and Environmental Applications; M.R. Hamblin and G. Jori Eds; The Royal Society of Chemistry, Thomas Graham House: Cambridge, 2011, pp. 361-375.
78. Smijs, T.G; Pavel, S.; Talebi, M.; Bouwstra, J.A. Preclinical studies with 5,10,15-Tris(4-methylpyridinium)-20-phenyl-(21H,23H)-porphine trichloride for the photodynamic treatment of superficial mycoses caused by Trychophyton rubrum. Photochem. Photobiol., 2009, 85, 733-739.
79. Bliss, J. M.; Bigelow, C.E.; Foster, T.H.; Haidaris, C.G. Susceptibility of Candida species to photodynamic effects of photofrin. Antimicrob. Agents Chemother., 2004, 48, 2000-2006. (Pubitemid 38691589)
80. Lambrechts, S.A.; Aalders, M.C.; Van Marle, J. Mechanistic study of the photodynamic inactivation of Candida albicans by a cationic porphyrin. Antimicrob. Agents Chemother., 2005, 49, 2026-2034. (Pubitemid 40631621)
81. Chabrier-Rosello, Y.; Giesselman, B.R.; De Jesus-Andino, F.J.; Foster, T.H.; Mitra S.; Haidaris, C. G. Inhibition of electron transport chain assembly and function promotes photodynamic killing of Candida. J. Photochem. Photobiol. B, 2010, 99,117-125.
82. Lam, M.; Jou1, P.C.; Lattif, A.A.; Lee, Y.; Malbasa, C.L.; Mukherjee, P.K.; Oleinick, N.L.; Ghannoum, M.A.; Cooper, K.D.; Baron, E.D. Photodynamic therapy with Pc 4 Induces apoptosis of Candida albicans. Photochem. Photobiol., 2011, 87, 904-909.
83. Alouini, Z.; Jemli, M. Destruction of helminth eggs by photosensitized porphyrin J. Environ. Monit., 2001, 3, 548-551. (Pubitemid 32999902)
84. Gubler, D.J. Insects in Disease Transmission. In: Hunter tropical medicine, 7th edition, Strickland G. T. editor. W. B. Saunders: Philadelphia (PA), 1991, pp. 981-1000.
85. Gubler, D.J. Resurgent vector-borne diseases as a global health problem. Emerg. Infect. Dis., 1998, 4, 442-450. (Pubitemid 28387429)
86. Alrajhi, A.A. Cutaneous leishmaniasis of the Old Word. Skin Therapy Lett., 2003, 8, 1-4.
87. Akilov O.E.; Sallum, U.W.; Hasan, T. In: Photodynamic inactivation of microbial pathogens. Medical and Environmental Applications; M.R. Hamblin and G. Jori Eds; The Royal Society of Chemistry, Thomas Graham House: Cambridge, 2011, pp. 303-326.
88. Smith, O.M.; Dolan, S.A.; Dvorak, J.A.; Wellems, T. E.; Sieber, F. Merocyanine 540-sensitized photoinactivation of human erythrocytes parasitized by Plasmodium falciparum. Blood, 1992, 80, 21-24.
89. Lustigman, S.; Ben-Hur, E. Photosensitized inactivation of Plasmodium falciparum in human red cells by phthalocyanines. Transfusion, 1996, 36, 543-546. (Pubitemid 26234639)
90. Grellier, P.; Santus, R.; Mouray, E.; Agmon, V.; Maziere,J.C.; Rigomier, D.; Dagan, A.; Gatt, S. Photosensitized inactivation of Plasmodium falciparum and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang., 1997, 72, 211-220. (Pubitemid 27277713)
91. Zhao, X.J.; Lustigman, S.; Li, Y.S.; Kenney, M.E.; Ben-Hur, E. Structureactivity and mechanism studies on silicon phthalocyanines with Plasmodium falciparum in the dark and under red light. Photochem. Photobiol., 1997, 66, 282-287. (Pubitemid 127470179)
92. Smith, T.G.; Kain, K.C. Inactivation of Plasmodium falciparum by photodynamic excitation of heme-cycle intermediates derived from β-Aminolevulinic acid. J. Infect. Dis., 2004, 190, 184-191. (Pubitemid 38858420)
93. Gottlieb, P.; Shen, L.G.; Chimezie, E.; Bahng, S.; Kenney, M.E.; Horowitz, B.; Ben-Hur, E. Inactivation of Trypanosoma cruzi trypomastigote forms in blood components by photodynamic treatment with phthalocyanines. Photochem. Photobiol, 1995, 62, 869-874.
94. Murray, H.W.; Nathan, C.F. Macrophage microbicidal mechanisms in vivo: Reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med., 1999, 189, 741-746. (Pubitemid 29193376)
95. Mishra, J.; Saxena, A.; Singh, S. Chemotherapy of leishmaniasis: Past, present and future. Curr. Med. Chem., 2007, 14, 1153-1169. (Pubitemid 46679457)
96. Croft, S.L.; Sundar, S.; Fairlamb, A.H. Drug resistance in leishmaniasis. Clin. Microbiol. Rev., 2006, 19, 111-126. (Pubitemid 43157649)
97. Asilian, A.; Davami, M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: A placebo-controlled, randomized clinical trial. Clin. Exp. Dermatol., 2006, 31, 634-637. (Pubitemid 44086787)
98. Kosaka, S.; Akilov, O.E.; O'Riordan, K.; Hasan, T. A mechanistic study of delta-Aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis. J. Invest. Dermatol., 2007, 127, 1546-1549. (Pubitemid 46762980)
99. Bristow, C.-A.; Hudson, R.; Paget, T.A.; Boyle, R.W. Potential of cationic porphyrins for photodynamic treatment of cutaneous leishmaniasis. Photodiag. Photodyn. Ther., 2006, 3, 162-167. (Pubitemid 44143044)
100. Enk, C.D.; Fritsch, C.; Jonas, F.; Nasereddin, A.; Ingber, A.; Jaffe, C. L.; Ruzicka, T. Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch. Dermatol., 2003, 139, 432-434. (Pubitemid 36427606)
101. Gardlo, K.; Horska, Z.; Enk, C.D.; Rauch, L.; Megahed, M.; Ruzicka, T.; Fritsch, C. Treatment of cutaneous leishmaniasis by photodynamic therapy. J. Am. Acad. Dermatol., 2003, 48, 893-896. (Pubitemid 36706223)
102. Gardlo, K.; Hanneken, S.; Ruzicka, T.; Neumann, N.J. Photodynamic therapy of cutaneous leishmaniasis. A promising new therapeutic modality. Hautarzt, 2004, 55, 381-383. (Pubitemid 38661284)
103. Dutta, S.; Ray, D.; Kolli, B.K.; Chang, K.-P. Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminium phthalocyanine chloride for photolysis in vitro. Antimicrob. Agents Chemother., 2005, 49, 4474-4484. (Pubitemid 41552575)
104. Konan, Y.N.; Gurny, R.; Allemann, E. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B, 2002, 66, 89-106. (Pubitemid 34240266)
105. Ben Amor, T., Tronchin, M., Bortolotto, L., Verdiglione, R., Jori, G. Porphyrins and related compounds as photoactivable insecticides. 1. Phototoxic activity of haematoporphyrin toward Ceratitis capitata and Bactrocera olea, Photochem. Photobiol. 1998, 67, 206-211. (Pubitemid 128472260)
106. Ben Amor, T.; Jori, G. Sunlight-Activated insecticides: Historical background and mechanisms of phototoxic activity. Insect Biochem. Mol. Biol., 2000, 30, 915-925.
107. Wohllebe, S., Richter, R., Richter, P., Hader, D.P. Photodynamic control of human pathogenic parasites in aquatic ecosystems using chlorophyllin and pheophorbid as photodynamic substances. Parasitol. Res. 2009, 104, 593-600.
108. Awad, H.H., El-Tayeb, T.A., Abd El-Aziz, N.M., Abdelkader, H. A semifield study on the effect of novel hematoporphyrin formula on the control of Culex pipiens larvae. J. Agri. Soc. Sci., 2008, 4, 85-88.
109. Dondji, B., Duchon, S., Diabate, A., Herve, J.P., Corbel, V., Hougard, J.M., Santus, R., Schrevel, J. Assessment of laboratory and field assays of sunlight-induced killing of mosquito larvae by photosensitizers. J. Med. Entomol. 2005, 42, 652-656. (Pubitemid 41040469)
110. Lucantoni, L., Magaraggia, M., Lupidi, G., Ouedraogo, R., Coppellotti, O., Esposito, F., Fabris, C., Jori, G., Habluetzel, A. Novel, Meso-substituted Cationic Porphyrin Molecule for Photo-mediated Larval Control of the Dengue Vector Aedes aegypti. PLoS Neglected Tropical Diseases, in press, 2012.